These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 1906877

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Recombinant expression of mutations causing von Willebrand disease type Normandy: characterization of a combined defect of factor VIII binding and multimerization.
    Schneppenheim R, Lenk H, Obser T, Oldenburg J, Oyen F, Schneppenheim S, Schwaab R, Will K, Budde U.
    Thromb Haemost; 2004 Jul; 92(1):36-41. PubMed ID: 15213842
    [Abstract] [Full Text] [Related]

  • 23. Characterisation of type 2N von Willebrand disease using phenotypic and molecular techniques.
    Nesbitt IM, Goodeve AC, Guilliatt AM, Makris M, Preston FE, Peake IR.
    Thromb Haemost; 1996 Jun; 75(6):959-64. PubMed ID: 8822593
    [Abstract] [Full Text] [Related]

  • 24. Combination therapy with von Willebrand factor concentrate plus recombinant factor VIII during cesarean section in a patient with type 3 von Willebrand disease and a low inhibitor titer: a case report.
    Chikasawa Y, Hagiwara T, Bingo M, Amano K, Kikuchi S, Mitsuhashi A, Shinozawa K, Fukutake K, Kinai E.
    Int J Hematol; 2022 Oct; 116(4):622-629. PubMed ID: 35532874
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance.
    Terraube V, O'Donnell JS, Jenkins PV.
    Haemophilia; 2010 Jan; 16(1):3-13. PubMed ID: 19473409
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A, Hermans C, Berneman Z, Schroyens W, Deckmyn H, Michiels JJ.
    Acta Haematol; 2009 Jan; 121(2-3):71-84. PubMed ID: 19506352
    [Abstract] [Full Text] [Related]

  • 32. N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets.
    Lanke E, Kristoffersson AC, Isaksson C, Holmberg L, Lethagen S.
    Eur J Haematol; 2008 Nov; 81(5):384-90. PubMed ID: 18637125
    [Abstract] [Full Text] [Related]

  • 33. Alloantibody from a patient with severe von Willebrand disease inhibits von Willebrand factor-FVIII interaction.
    Batlle J, Lourés E, Vila P, Hernández MC, Méndez JA, Torea J, Rendal E, Couselo MJ, Filgueira A, López Fernández MF.
    Ann Hematol; 1997 Sep; 75(3):111-5. PubMed ID: 9368480
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII.
    López-Fernández MF, Blanco-López MJ, Castiñeira MP, Batlle J.
    Am J Hematol; 1992 May; 40(1):20-7. PubMed ID: 1566742
    [Abstract] [Full Text] [Related]

  • 37. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U.
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A common splice site mutation is shared by two families with different type 2N von Willebrand disease mutations.
    Nesbitt IM, Hampton KK, Preston FE, Peake IR, Goodeve AC.
    Thromb Haemost; 1999 Sep; 82(3):1061-4. PubMed ID: 10494764
    [Abstract] [Full Text] [Related]

  • 40. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
    Castaman G, Federici AB, Rodeghiero F, Mannucci PM.
    Haematologica; 2003 Jan; 88(1):94-108. PubMed ID: 12551832
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.